ChengDa Pharmaceuticals Co. Ltd. Free Cash Flow Generation Index
ChengDa Pharmaceuticals Co. Ltd. free cash flow generation index. ChengDa Pharmaceuticals Co. Ltd. (301201) has a Free Cash Flow Generation Index of -1.03x as of December 2025. Free cash flow of CN¥-35.00 Million represents -1% of operating cash flow (CN¥34.02 Million). Check ChengDa Pharmaceuticals Co. Ltd. (301201) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of ChengDa Pharmaceuticals Co. Ltd. (2019–2025)
Free cash flow generation index of ChengDa Pharmaceuticals Co. Ltd. from 2019 to 2025. Historical FCF Generation Index trend for ChengDa Pharmaceuticals Co. Ltd. across 7 annual periods. Explore 301201 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
ChengDa Pharmaceuticals Co. Ltd. Free Cash Flow Generation Index by Year (2019–2025)
ChengDa Pharmaceuticals Co. Ltd. free cash flow generation index by year from 2019 to 2025. Year-by-year Free Cash Flow Generation Index for ChengDa Pharmaceuticals Co. Ltd.. For the full cash flow conversion analysis, see ChengDa Pharmaceuticals Co. Ltd. operating cash flow efficiency.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.03x | CN¥-35.00 Million | CN¥34.02 Million | CN¥69.02 Million | ▲ +88.6% |
| 2024 | -9.00x | CN¥-257.72 Million | CN¥28.65 Million | CN¥286.36 Million | ▼ -5200.6% |
| 2023 | -0.17x | CN¥-32.60 Million | CN¥192.07 Million | CN¥224.67 Million | ▲ +94.9% |
| 2022 | -3.32x | CN¥-158.03 Million | CN¥47.67 Million | CN¥205.69 Million | ▼ -396.1% |
| 2021 | -0.67x | CN¥-55.56 Million | CN¥83.14 Million | CN¥138.70 Million | ▼ -232.3% |
| 2020 | 0.51x | CN¥65.16 Million | CN¥128.97 Million | CN¥63.81 Million | ▲ +107.2% |
| 2019 | 0.24x | CN¥16.46 Million | CN¥67.52 Million | CN¥51.06 Million | — |